Tag Archives: Australia

BIO Submits Comments on “Myriad” PTO Patent Guidance

Supreme Court - Phil Roeder

On July 31st, BIO, alongside a group of international bioindustry trade associations submitted comments to the United States Patent and Trademark Office regarding their March 4, 2014 Guidance on patent subject matter eligibility. Representing associations from Japan, Australia, Canada, the UK, Germany, Spain, Portugal Belgium, the Netherlands and others, the comments reflect a deep concern among the international community regarding how the PTO is interpreting the Supreme Court’s recent decisions in Mayo v. Prometheus and Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,

Five Countries, One Goal: Collaboration with Global Impact in the Life Sciences Industry

MLSC

During the 2013 BIO International Convention, the Massachusetts Life Sciences Center (MLSC) and regions from four other countries launched the new International Collaborative Industry Program (ICIP). The MLSC will partner with Victoria, Australia; the Wallonia region of Belgium; Quebec, Canada; and Alsace in France to award funding to projects promoting innovative and collaborative research and development (R&D) between companies in Massachusetts and in the partnering regions. The program’s goal is to develop long-term collaborations to advance late-stage R&D projects in biotechnology, pharmaceuticals, medical Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Gene Patents: Common Sense from Down Under

Credit - australiaphotos.co.uk

Oh, crikey! The U.S. Supreme Court is currently reviewing briefs to consider whether preparations of DNA molecules are patentable. Possibly unnoticed to the Justices is a recent decision from the Federal Court of Australia confirming the patentability of ‘isolated’ DNA. The Supreme Court may not take any notice of this Australian case, but those following so-called gene patents can learn a lot from the no-nonsense approach of Aussie patent law. The Australian case focuses its Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: ,

Australian Senate Committee Recommends Against Banning ‘Gene Patents’

Australian Parliament House

The Australian Senate Legal and Constitutional Affairs Legislation Committee recommended against the Patent Amendment (Human Genes and Biological Materials) which would have banned DNA patents in Australia.  The push by members of the Australian Senate seemed to mirror efforts in the United States surrounding the Myriad case. The Committee found that: “While previous inquiries and public discussions have focused on the patenting of human genes, the Bill goes further and proposes a specific exclusion for biological materials which Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,

The Global Biotech Industry Comes to BIO

The world’s largest biotech hubs are busy planning their delegations’ visits to the BIO International Convention next month. The international program at the Convention will be one of the most robust to date, with international case studies, breakout sessions focused on globalization and Super Sessions focused on the emerging markets. BIOtechNOW is profiling a few of the top delegations to give you a preview*: Australia: Australia’s biotech sector, along with the broader Australian economy, performed Read More >

Corporate, Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,